Literature DB >> 6490418

Interstitial radiation therapy for carcinoma of the penis using iridium 192 wires: the Henri Mondor experience (1970-1979).

J J Mazeron, D Langlois, P A Lobo, J A Huart, E Calitchi, A Lusinchi, M Raynal, J P Le Bourgeois, C C Abbou, B Pierquin.   

Abstract

From 1970 to 1979, a group of 50 patients was treated for squamous cell carcinoma of the penis by interstitial irradiation using an afterloading technique and iridium 192 wires. The group included 9 patients with T1 tumors, 27 with T2 tumors, and 14 with T3 tumors. Forty-five patients presented with no metastatic inguinal nodes (N0), 3 patients with N1 nodes, and 2 patients had N3 nodes. After treatment, 11 patients (1 T1, 6 T2 and 4T3) developed local recurrences; 10 of these 11 patients underwent penile amputation which controlled the tumor in 7 of the patients. One patient refused amputation. Three patients developed post-therapeutic necrosis which necessitated partial amputation in 2 cases. Eight patients developed post-therapeutic urethral stenosis, which required surgical treatment in three of the cases. Overall, at their last follow-up examinations, 74% of the patients were free of disease with conservation of penile morphology and function. Most patients without metastatic nodes (37/45) at diagnosis did not receive prophylatic treatment of the groin. Two of these patients developed delayed metastatic nodes; one was successfully salvaged. All 5 patients presenting with metastatic nodes at diagnosis died, four with uncontrolled regional disease. Twenty-one percent of the patients died of their disease. We advocate interstitial irradiation using iridium 192 wires for the treatment of non-infiltrating or moderately infiltrating squamous cell carcinoma of the penis in which the largest dimension does not exceed 4 cm. Pre-implant circumcision and regular long-term follow-up are necessary. More extensive tumors are better managed surgically. When regular follow-up can be assured, it is reasonable to forgo prophylactic treatment of the inguinal nodes in patients presenting without groin metastasis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6490418     DOI: 10.1016/0360-3016(84)90268-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  11 in total

1.  Interstitial brachytherapy in carcinoma of the penis.

Authors:  A J Chaudhary; S Ghosh; R L Bhalavat; J N Kulkarni; B V Sequeira
Journal:  Strahlenther Onkol       Date:  1999-01       Impact factor: 3.621

2.  Radiation therapy in the management of the primary penile tumor: an update.

Authors:  Juanita Crook; Clement Ma; Laval Grimard
Journal:  World J Urol       Date:  2008-07-18       Impact factor: 4.226

3.  Survival Following Salvage Surgery after Failed Radiotherapy for Penile Cancer: A SEER-Based Study.

Authors:  Mahmoud I Khalil; Fei Wan; Ehab Eltahawy; Rodney Davis; Philippe E Spiess; Nabil K Bissada; Mohamed H Kamel
Journal:  Curr Urol       Date:  2019-05-10

4.  Interstitial brachytherapy for penile cancer: the experience of Oncology Centre in Bydgoszcz.

Authors:  Roman Makarewicz; Andrzej Lebioda; Joanna Terlikiewicz; Renata Kabacińska
Journal:  J Contemp Brachytherapy       Date:  2011-01-14

Review 5.  Contemporary role of radiotherapy in the management of penile cancer.

Authors:  Martin Arthur Korzeniowski; Juanita Mary Crook
Journal:  Transl Androl Urol       Date:  2017-10

6.  Penile cancer brachytherapy HDR mould technique used at the Holycross Cancer Center.

Authors:  Robert Matys; Iwona Kubicka-Mendak; Jarosław Lyczek; Piotr Pawłowski; Iwona Stawiarska; Joanna Miedzinska; Paweł Banatkiewicz; Aldona Laskawska-Wiatr; Justyna Wittych
Journal:  J Contemp Brachytherapy       Date:  2011-12-30

7.  High-dose rate brachytherapy in localized penile cancer: short-term clinical outcome analysis.

Authors:  Yohann Rouscoff; Alexander Tuan Falk; Matthieu Durand; Jocelyn Gal; Marie-Eve Chand; Mathieu Gautier; Alexandre Marsaud; Daniel Chevallier; Jean Amiel; Jean-Michel Hannoun-Levi
Journal:  Radiat Oncol       Date:  2014-06-19       Impact factor: 3.481

8.  Low-dose brachytherapy for early stage penile cancer: a 20-year single-institution study (73 patients).

Authors:  A Cordoba; A Escande; S Lopez; L Mortier; X Mirabel; B Coche-Déqueant; E Lartigau
Journal:  Radiat Oncol       Date:  2016-07-27       Impact factor: 3.481

Review 9.  Penile-sparing modalities in the management of low-stage penile cancer.

Authors:  Paurush Babbar; Nitin Yerram; Alice Crane; Daniel Sun; Kyle Ericson; Andrew Sun; Abhinav Khanna; Hadley Wood; Andrew Stephenson; Kenneth Angermeier
Journal:  Urol Ann       Date:  2018 Jan-Mar

10.  Comparison of efficacy between brachytherapy and penectomy in patients with penile cancer: a meta-analysis.

Authors:  Xiheng Hu; Jianghai Huang; Sailan Wen; Jun Fu; Minfeng Chen
Journal:  Oncotarget       Date:  2017-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.